Literature DB >> 11743546

Natural history of claudication: long-term serial follow-up study of 1244 claudicants.

R Aquino1, C Johnnides, M Makaroun, J C Whittle, V S Muluk, M E Kelley, S C Muluk.   

Abstract

OBJECTIVE: The purpose of this study was to delineate the natural history of claudication and determine risk factors for ischemic rest pain (IRP) and ischemic ulceration (IU) among patients with claudication.
METHODS: We prospectively collected data on 1244 men with claudication during a 15-year period, including demographics, clinical risk factors, and ankle-brachial index (ABI). We followed these patients serially with ABIs, self-reported walking distance (WalkDist), and monitoring for IRP and IU. We used Kaplan-Meier and proportional hazards modeling to find independent predictors of IRP and IU.
RESULTS: Mean follow-up was 45 months; statistically valid follow-up could be carried out for as long as 12 years. ABI declined an average of 0.014 per year. WalkDist declined at an average rate of 9.2 yards per year. The cumulative 10-year risks of development of IU and IRP were 23% and 30%, respectively. In multivariate analysis using several clinical risk factors, we found that only DM (relative risk [RR], 1.8) and ABI (RR, 2.2 for 0.1 decrease in ABI) predicted the development of IRP. Similarly, only DM (RR, 3.0) and ABI (RR, 1.9 for 0.1 decrease in ABI) were significant predictors of IU.
CONCLUSION: This large serial study of claudication is, to our knowledge, the longest of its kind. We documented an average rate of ABI decline of 0.014 per year and a decline in WalkDist of 9.2 yards per year. Two clinical factors, ABI and DM, were found to be associated with the development of IRP and IU. Our findings may be useful in predicting the clinical course of claudication.

Entities:  

Mesh:

Year:  2001        PMID: 11743546     DOI: 10.1067/mva.2001.119749

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  23 in total

1.  Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule.

Authors:  Bianca Lw Bendermacher; Joep Aw Teijink; Edith M Willigendael; Marie-Louise Bartelink; Harry R Büller; Ron Jg Peters; Jelis Boiten; Machteld Langenberg; Martin H Prins
Journal:  Br J Gen Pract       Date:  2006-12       Impact factor: 5.386

Review 2.  Endovascular intervention for peripheral artery disease.

Authors:  Arun K Thukkani; Scott Kinlay
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

3.  Microvascular Disease, Peripheral Artery Disease, and Amputation.

Authors:  Joshua A Beckman; Meredith S Duncan; Scott M Damrauer; Quinn S Wells; Joey V Barnett; David H Wasserman; Roger J Bedimo; Adeel A Butt; Vincent C Marconi; Jason J Sico; Hilary A Tindle; Marc P Bonaca; Aaron W Aday; Matthew S Freiberg
Journal:  Circulation       Date:  2019-07-08       Impact factor: 29.690

4.  Lower extremity nerve function in patients with lower extremity ischemia.

Authors:  Mary M McDermott; Robert Sufit; Takashi Nishida; Jack M Guralnik; Luigi Ferrucci; Lu Tian; Kiang Liu; Jin Tan; William H Pearce; Joseph R Schneider; Leena Sharma; Michael H Criqui
Journal:  Arch Intern Med       Date:  2006-10-09

5.  A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia.

Authors:  Ayotunde O Dokun; Sehoon Keum; Surovi Hazarika; Yongjun Li; Gregory M Lamonte; Ferrin Wheeler; Douglas A Marchuk; Brian H Annex
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

6.  Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study).

Authors:  T Bartsch; M Brehm; T Zeus; G Kögler; P Wernet; B E Strauer
Journal:  Clin Res Cardiol       Date:  2007-08-17       Impact factor: 5.460

Review 7.  Role of genetics in peripheral arterial disease outcomes; significance of limb-salvage quantitative locus-1 genes.

Authors:  Emmanuel Okeke; Ayotunde O Dokun
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-03

8.  Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants.

Authors:  Terence E Ryan; Dean J Yamaguchi; Cameron A Schmidt; Tonya N Zeczycki; Saame Raza Shaikh; Patricia Brophy; Thomas D Green; Michael D Tarpey; Reema Karnekar; Emma J Goldberg; Genevieve C Sparagna; Maria J Torres; Brian H Annex; P Darrell Neufer; Espen E Spangenburg; Joseph M McClung
Journal:  JCI Insight       Date:  2018-11-02

Review 9.  Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation.

Authors:  Louis L Nguyen
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

10.  DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents in the common iliac artery: study protocol for a randomized controlled trial.

Authors:  Joost A Bekken; Jan Albert Vos; Ruud A Aarts; Jean-Paul P M de Vries; Bram Fioole
Journal:  Trials       Date:  2012-11-19       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.